Clinical Trials List
Protocol NumberCC-486-NPC-001
2015-02-01 - 2016-12-31
Phase II
Terminated3
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林伯儒 Division of Radiation Therapy
- 陳冠文 Division of Radiation Therapy
- 陳建志 Division of Radiation Therapy
- YI-CHUN LIU Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃泰霖 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- Meng-Jer Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
55 participants
